My NCBI | Sign In
RSS Settings
  • Search: Sharpe ED[au]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 24

    1.

    The safety and efficacy of brinzolamide 1%/timolol 0.5% fixed combination versus dorzolamide 2%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.

    Manni G, Denis P, Chew P, Sharpe ED, Orengo-Nania S, Coote MA, Laganovska G, Volksone L, Zeyen T, Filatori I, James J, Aung T.

    J Glaucoma. 2009 Apr-May;18(4):293-300.PMID: 19365194 [PubMed - indexed for MEDLINE]Related articles

    2.

    Long-term progression at individual mean intraocular pressure levels in primary open-angle and exfoliative glaucoma.

    Stewart WC, Kolker AE, Sharpe ED, Day DG, Konstas AG, Hollo G, Astakhov YS, Teus MA, Stewart JA.

    Eur J Ophthalmol. 2008 Sep-Oct;18(5):765-70.PMID: 18850556 [PubMed - indexed for MEDLINE]Related articles

    3.

    A comparison of dorzolamide/timolol-fixed combination versus bimatoprost in patients with open-angle glaucoma who are poorly controlled on latanoprost.

    Sharpe ED, Williams RD, Stewart JA, Nelson LA, Stewart WC.

    J Ocul Pharmacol Ther. 2008 Aug;24(4):408-13.PMID: 18627340 [PubMed - indexed for MEDLINE]Related articles

    4.

    The clinical impact and incidence of periocular pigmentation associated with either latanoprost or bimatoprost therapy.

    Sharpe ED, Reynolds AC, Skuta GL, Jenkins JN, Stewart WC.

    Curr Eye Res. 2007 Dec;32(12):1037-43.PMID: 18085467 [PubMed - indexed for MEDLINE]Related articles

    5.

    Success rates for switching to dorzolamide/timolol fixed combination in timolol responders who are insufficiently controlled by latanoprost monotherapy.

    Sonty S, Henry JC, Sharpe ED, Weiss MJ, Stewart JA, Nelson LA, Stewart WC.

    Acta Ophthalmol. 2008 Jun;86(4):419-23. Epub 2007 Nov 26.PMID: 18039347 [PubMed - indexed for MEDLINE]Related articles

    6.

    Mean intraocular pressure and progression based on corneal thickness in patients with ocular hypertension.

    Konstas AG, Irkec MT, Teus MA, Cvenkel B, Astakhov YS, Sharpe ED, Hollo G, Mylopoulos N, Bozkurt B, Pizzamiglio C, Potyomkin VV, Alemu AM, Nasser QJ, Stewart JA, Stewart WC.

    Eye (Lond). 2009 Jan;23(1):73-8. Epub 2007 Oct 5.PMID: 17917683 [PubMed - indexed for MEDLINE]Related articles

    7.

    Safety and efficacy of bimatoprost 0.03% versus timolol maleate 0.5%/dorzolamide 2% fixed combination.

    Day DG, Sharpe ED, Beischel CJ, Jenkins JN, Stewart JA, Stewart WC.

    Eur J Ophthalmol. 2005 May-Jun;15(3):336-42.PMID: 15945001 [PubMed - indexed for MEDLINE]Related articles

    8.

    The clinical validity of the treatment satisfaction survey for intraocular pressure in ocular hypertensive and glaucoma patients.

    Day DG, Sharpe ED, Atkinson MJ, Stewart JA, Stewart WC.

    Eye (Lond). 2006 May;20(5):583-90.PMID: 15933751 [PubMed - indexed for MEDLINE]Related articles

    9.

    A persistency and economic analysis of latanoprost, bimatoprost, or beta-blockers in patients with open-angle glaucoma or ocular hypertension.

    Day DG, Schacknow PN, Sharpe ED, Ellyn JC, Kulze JC 3rd, Threlkeld AB, Jones ED, Brown RH, Jenkins JN, Stewart WC.

    J Ocul Pharmacol Ther. 2004 Oct;20(5):383-92.PMID: 15650513 [PubMed - indexed for MEDLINE]Related articles

    10.

    Brimonidine purite 0.15% versus dorzolamide 2% each given twice daily to reduce intraocular pressure in subjects with open angle glaucoma or ocular hypertension.

    Sharpe ED, Day DG, Beischel CJ, Rhodes JS, Stewart JA, Stewart WC.

    Br J Ophthalmol. 2004 Jul;88(7):953-6.PMID: 15205246 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Brimonidine 0.2% vs unoprostone 0.15% both added to timolol maleate 0.5% given twice daily to patients with primary open-angle glaucoma or ocular hypertension.

    Sharpe ED, Henry CJ, Mundorf TK, Day DG, Stewart JA, Jenkins JN, Stewart WC.

    Eye (Lond). 2005 Jan;19(1):35-40.PMID: 15094733 [PubMed - indexed for MEDLINE]Related articles

    12.

    Efficacy and safety of the latanoprost/timolol maleate fixed combination vs concomitant brimonidine and latanoprost therapy.

    Stewart WC, Stewart JA, Day DG, Sharpe ED, Jenkins JN.

    Eye (Lond). 2004 Oct;18(10):990-5.PMID: 15037890 [PubMed - indexed for MEDLINE]Related articles

    13.

    Efficacy and safety of timolol maleate/latanoprost fixed combination versus timolol maleate and brimonidine given twice daily.

    Stewart WC, Stewart JA, Day D, Sharpe ED.

    Acta Ophthalmol Scand. 2003 Jun;81(3):242-6.PMID: 12780402 [PubMed - indexed for MEDLINE]Related articles

    14.

    Timolol 0.5%/dorzolamide 2% fixed combination vs timolol maleate 0.5% and unoprostone 0.15% given twice daily to patients with primary open-angle glaucoma or ocular hypertension.

    Day DG, Schacknow PN, Wand M, Sharpe ED, Stewart JA, Leech J, Stewart WC.

    Am J Ophthalmol. 2003 Feb;135(2):138-43.PMID: 12566015 [PubMed - indexed for MEDLINE]Related articles

    15.

    The safety and efficacy of timolol 0.5% in xanthan gum versus timolol gel forming solution 0.5%.

    Stewart WC, Sharpe ED, Stewart JA, Hott CE.

    Curr Eye Res. 2002 May;24(5):387-91.PMID: 12434307 [PubMed - indexed for MEDLINE]Related articles

    16.

    An economic analysis of switching to latanoprost from a beta-blocker or adding brimonidine or latanoprost to a beta-blocker in open-angle glaucoma or ocular hypertension.

    Stewart WC, Leech J, Sharpe ED, Kulze J, Ellyn J, Day DG.

    Am J Manag Care. 2002 Aug;8(10 Suppl):S240-8.PMID: 12188166 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Additive efficacy of unoprostone isopropyl 0.12% (rescula) to latanoprost 0.005%.

    Stewart WC, Sharpe ED, Stewart JA, Holmes KT, Latham KE.

    Am J Ophthalmol. 2001 Mar;131(3):339-44.PMID: 11239866 [PubMed - indexed for MEDLINE]Related articles

    18.

    Factors associated with long-term progression or stability in primary open-angle glaucoma.

    Stewart WC, Kolker AE, Sharpe ED, Day DG, Holmes KT, Leech JN, Johnson M, Cantrell JB.

    Am J Ophthalmol. 2000 Sep;130(3):274-9.PMID: 11020404 [PubMed - indexed for MEDLINE]Related articles

    19.

    Brimonidine 0.2% versus dorzolamide 2% each given three times daily to reduce intraocular pressure.

    Stewart WC, Sharpe ED, Harbin TS Jr, Pastor SA, Day DG, Holmes KT, Stewart JA.

    Am J Ophthalmol. 2000 Jun;129(6):723-7.PMID: 10926979 [PubMed - indexed for MEDLINE]Related articles

    20.

    Comparison of the efficacy and safety of latanoprost 0.005% compared to brimonidine 0.2% or dorzolamide 2% when added to a topical beta-adrenergic blocker in patients with primary open-angle glaucoma or ocular hypertension.

    Stewart WC, Sharpe ED, Day DG, Kolker AE, Konstas AG, Lee WH, Rieser JC, Chopra H, Holmes KT.

    J Ocul Pharmacol Ther. 2000 Jun;16(3):251-9.PMID: 10872922 [PubMed - indexed for MEDLINE]Related articles

    21.

    Efficacy and safety of timolol solution once daily vs timolol gel added to latanoprost.

    Stewart WC, Day DG, Sharpe ED, Dubiner HB, Holmes KT, Stewart JA.

    Am J Ophthalmol. 1999 Dec;128(6):692-6.PMID: 10612504 [PubMed - indexed for MEDLINE]Related articles

    22.

    Argon laser therapy of occult recurrent hyphema from anterior segment wound neovascularization.

    Sharpe ED, Simmons RJ.

    Ophthalmic Surg. 1986 May;17(5):283-5.PMID: 2425322 [PubMed - indexed for MEDLINE]Related articles

    23.

    A prospective comparison of Amvisc and Healon in cataract surgery.

    Sharpe ED, Simmons RJ.

    J Cataract Refract Surg. 1986 Jan;12(1):47-9.PMID: 3958952 [PubMed - indexed for MEDLINE]Related articles

    24.

    Argon laser trabeculoplasty as a means of decreasing intraocular pressure from "normal" levels in glaucomatous eyes.

    Sharpe ED, Simmons RJ.

    Am J Ophthalmol. 1985 Jun 15;99(6):704-7.PMID: 4014394 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    1 free full-text article in PubMed Central

    Find related data

    Search details

    » See more...

    Recent activity